Small-molecule inhibitors and the salivary gland epithelium in Sjögren’s syndrome

References

• Shiboski CH, Shiboski SC, Seror R, et al. 2016 American College of Rheumatology/European League against Rheumatism classification criteria for primary Sjögren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis. 2017;76:9–16.
   PubMed Web of Science ®Google Scholar
• Hjelmervik TOR, Petersen K, Jonassen I, et al. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren’s syndrome patients from healthy control subjects. Arthritis Rheum. 2005;52:1534–1544.
   PubMed Web of Science ®Google Scholar
• Gottenberg J-E, Cagnard N, Lucchesi C, et al. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren’s syndrome. Proc Natl Acad Sci U S A. 2006;103:2770–2775.
   PubMed Web of Science ®Google Scholar
• Haupl T, Biesen R, Smiljanovic B, et al. The type 1 interferon signature: facts, fads and fallacies. Ann Rheum Dis. 2011;70:A24–A24.
   Web of Science ®Google Scholar
• Igoe A, Scofield RH. Autoimmunity and infection in Sjögren’s syndrome. Curr Opin Rheumatol. 2013;25:480–487.
   PubMed Web of Science ®Google Scholar
• Nakayamada S, Tanaka Y. BAFF- and APRIL-targeted therapy in systemic autoimmune diseases. Inflamm Regen. 2016;36:6.
   PubMed Web of Science ®Google Scholar
• Pijpe J, Kalk WWI, Bootsma H, et al. Progression of salivary gland dysfunction in patients with Sjögren’s syndrome. Ann Rheum Dis. 2007;66:107–112.
   PubMed Web of Science ®Google Scholar
• Gannot G, Lancaster HE, Fox PC. Clinical course of primary Sjögren’s syndrome: salivary, oral, and serologic aspects. J Rheumatol. 2000;27:1905–1909.
   PubMed Web of Science ®Google Scholar
• Jonsson R, Kroneld U, Backman K, et al. Progression of sialadenitis in Sjögren’s sydrome. Br J Rheumatol. 1993;32:578–581.
   PubMedGoogle Scholar
• Teos LY, Zhang Y, Cotrim AP, et al. IP3R deficit underlies loss of salivary fluid secretion in Sjögren’s syndrome. Sci Rep. 2015;5:13953.
   PubMed Web of Science ®Google Scholar
• Ambudkar IS. Ca2+ signaling and regulation of fluid secretion in salivary gland acinar cells. Cell Calcium. 2014;55:297.
   PubMed Web of Science ®Google Scholar
• Perl A. Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases. Nat Rev Rheumatol. 2016;12:169–182.
   PubMed Web of Science ®Google Scholar
• Villarino AV, Kanno Y, Ferdinand JR, et al. Mechanisms of Jak/STAT signaling in immunity and disease. J Immunol. 2015;194:21–27.
   PubMed Web of Science ®Google Scholar
• O’Shea JJ, Kontzias A, Yamaoka K, et al. Janus kinase inhibitors in autoimmune diseases. Ann Rheum Dis. 2013;72(Suppl 2):ii111–5.
   PubMed Web of Science ®Google Scholar
• Gadina M, Gazaniga N, Vian L, et al. Small molecules to the rescue: inhibition of cytokine signaling in immune-mediated diseases. J Autoimmun. 2017;85:20–31.
   PubMed Web of Science ®Google Scholar
• Ong HL, Subedi KP, Son G-Y, et al. Tuning store-operated calcium entry to modulate Ca2+-dependent physiological processes. Biochim Biophys Acta - Mol Cell Res. 2019;1866:1037–1045.
   PubMed Web of Science ®Google Scholar
• Aure MH, Konieczny SF, Ovitt CE. Salivary gland homeostasis is maintained through acinar cell self-duplication. Dev Cell. 2015;33:231–237.
   PubMed Web of Science ®Google Scholar
• Pringle S, Maimets M, van der Zwaag M, et al. Human salivary gland stem cells functionally restore radiation damaged salivary glands. Stem Cells. 2016;34:640–652.
   PubMed Web of Science ®Google Scholar
• Dimitriou ID, Kapsogeorgou EK, Abu-Helu RF, et al. Establishment of a convenient system for the long-term culture and study of non-neoplastic human salivary gland epithelial cells. Eur J Oral Sci. 2002;110:21–30.
   PubMed Web of Science ®Google Scholar
• Pringle S, Wang X, Verstappen GMPJ, et al. Salivary gland stem cells age prematurely in primary Sjögren’s syndrome. Arthritis Rheumatol. 2019;71:133–142.
   PubMed Web of Science ®Google Scholar
• Clevers H. Modeling development and disease with organoids. Cell. 2016;165:1586–1597.
   PubMed Web of Science ®Google Scholar
• Routsias JG, Tzioufas AG. Autoimmune response and target autoantigens in Sjogren’s syndrome. Eur J Clin Invest. 2010;40:1026–1036.
   PubMed Web of Science ®Google Scholar
• Manoussakis MN, Spachidou MP, Maratheftis CI. Salivary epithelial cells from Sjogren’s syndrome patients are highly sensitive to anoikis induced by TLR-3 ligation. J Autoimmun. 2010;35:212–218.
   PubMed Web of Science ®Google Scholar
• Varin -M-M, Guerrier T, Devauchelle-Pensec V, et al. In Sjögren’s syndrome, B lymphocytes induce epithelial cells of salivary glands into apoptosis through protein kinase C delta activation. Autoimmun Rev. 2012;11:252–258.
   PubMed Web of Science ®Google Scholar
• Ohlsson M, Jonsson R, Brokstad KA. Subcellular Redistribution and. Surface exposure of the Ro52, Ro60 and La48 autoantigens during apoptosis in human ductal epithelial cells: a possible mechanism in the pathogenesis of Sjogren’s syndrome. Scand J Immunol. 2002;56:456–469.
   PubMed Web of Science ®Google Scholar
• Lisi S, Sisto M, Lofrumento D, et al. Regulation of mRNA caspase-8 levels by anti-nuclear autoantibodies. Clin Exp Med. 2010;10:199–203.
   PubMed Web of Science ®Google Scholar
• Sisto M, Lisi S, Lofrumento D, et al. Autoantibodies from Sjögren’s syndrome trigger apoptosis in salivary gland cell line. Ann N Y Acad Sci. 2007;1108:418–425.
   PubMed Web of Science ®Google Scholar
• Blokland SLM, Hillen MR, Wichers CGK, et al. Increased mTORC1 activation in salivary gland B cells and T cells from patients with Sjögren’s syndrome: mTOR inhibition as a novel therapeutic strategy to halt immunopathology? RMD Open. 2019;5:e000701.
   PubMed Web of Science ®Google Scholar
• Soypaçacı Z, Gümüş ZZ, Çakaloğlu F, et al. Role of the mTOR pathway in minor salivary gland changes in Sjogren’s syndrome and systemic sclerosis. Arthritis Res Ther. 2018;20:170.
   PubMed Web of Science ®Google Scholar
• Manoussakis MN, Moutsopoulos HM. Sjögren’s syndrome: autoimmune epithelitis. Best Pract Res Clin Rheumatol. 2000;14:73–95.
   PubMed Web of Science ®Google Scholar
• Manoussakis MN, Kapsogeorgou EK. The role of intrinsic epithelial activation in the pathogenesis of Sjögren’s syndrome. J Autoimmun. 2010;35:219–224.
   PubMed Web of Science ®Google Scholar
• Ohlsson M, Szodoray P, Loro LL, et al. CD40, CD154, Bax and Bcl-2 expression in Sjogren’s syndrome salivary glands: a putative anti-apoptotic role during its effector phases. Scand J Immunol. 2002;56:561–571.
   PubMed Web of Science ®Google Scholar
• Sakai A, Sugawara Y, Kuroishi T, et al. Identification of IL-18 and Th17 cells in salivary glands of patients with Sjögren’s syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18. J Immunol. 2008;181:2898–2906.
   PubMed Web of Science ®Google Scholar
• Szyszko EA, Brokstad KA, Oijordsbakken G, et al. Salivary glands of primary Sjögren’s syndrome patients express factors vital for plasma cell survival. Arthritis Res Ther. 2011;13:R2.
   PubMed Web of Science ®Google Scholar
• Sfriso P, Oliviero F, Calabrese F, et al. Epithelial CXCR3-B regulates chemokines bioavailability in normal, but not in Sjogren’s syndrome, salivary glands. J Immunol. 2006;176:2581–2589.
   PubMed Web of Science ®Google Scholar
• Xanthou G, Polihronis M, Tzioufas AG, et al. “Lymphoid” chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjögren’s syndrome patients: possible participation in lymphoid structure formation. Arthritis Rheum. 2001;44:408–418.
   PubMed Web of Science ®Google Scholar
• Kawakami A, Nakashima K, Tamai M, et al. Toll-like receptor in salivary glands from patients with Sjögren’s syndrome: functional analysis by human salivary gland cell line. J Rheumatol. 2007;34:1019–1026.
   PubMed Web of Science ®Google Scholar
• Wang X, Shaalan A, Liefers S, et al. Dysregulation of NF-kB in glandular epithelial cells results in Sjögren’s-like features. Appel S, editor. PLoS One. 2018;13:e0200212.
   PubMed Web of Science ®Google Scholar
• Spachidou MP, Bourazopoulou E, Maratheftis CI, et al. Expression of functional toll-like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sjögren’s syndrome. Clin Exp Immunol. 2007;147:497–503.
   PubMed Web of Science ®Google Scholar
• Rusakiewicz S, Nocturne G, Lazure T, et al. NCR3/NKp30 contributes to pathogenesis in primary Sjogren’s syndrome. Sci Transl Med. 2013;5:195ra96.
   PubMed Web of Science ®Google Scholar
• Amft N, Curnow SJ, Scheel-Toellner D, et al. Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren’s syndrome. Arthritis Rheum. 2001;44:2633–2641.
   PubMed Web of Science ®Google Scholar
• Manoussakis MN, Spachidou MP, Maratheftis CI. Salivary epithelial cells from Sjogren’s syndrome patients are highly sensitive to anoikis induced by TLR-3 ligation. J Autoimmun. 2010;35:212–218.
   PubMed Web of Science ®Google Scholar
• Salomonsson S, Jonsson MV, Skarstein K, et al. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren’s syndrome. Arthritis Rheum. 2003;48:3187–3201.
   PubMed Web of Science ®Google Scholar
• Fox RI, Kang HI, Ando D, et al. Cytokine mRNA expression in salivary gland biopsies of Sjögren’s syndrome. J Immunol. 1994;152:5532–5539.
   PubMed Web of Science ®Google Scholar
• Delli K, Haacke EA, Kroese FGM, et al. Towards personalised treatment in primary Sjögren’s syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment. Ann Rheum Dis. 2016;75:1933–1938.
   PubMed Web of Science ®Google Scholar
• NIH National Library of medicine. ClinicalTrials.gov [Internet]. 2019.
   Google Scholar
• Lee S-J, Silverman E, Bargman JM. The role of antimalarial agents in the treatment of SLE and lupus nephritis. Nat Rev Nephrol. 2011;7:718–729.
   PubMed Web of Science ®Google Scholar
• Kuznik A, Bencina M, Svajger U, et al. Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines. J Immunol. 2011;186:4794–4804.
   PubMed Web of Science ®Google Scholar
• Takeda K, Akira S. Toll-like receptors. Curr Protoc Immunol. 2015;109:1–10.
   Google Scholar
• Hemmi H, Akira S. TLR signalling and the function of dendritic cells. Chem Immunol Allergy 2005;86:120-135.
   PubMedGoogle Scholar
• Karlsen M, Jakobsen K, Jonsson R, et al. Expression of toll-like receptors in peripheral blood mononuclear cells of patients with primary Sjögren’s syndrome. Scand J Immunol. 2017;85:220–226.
   PubMed Web of Science ®Google Scholar
• Dawson LJ, Caulfield VL, Stanbury JB, et al. Hydroxychloroquine therapy in patients with primary Sjögren’s syndrome may improve salivary gland hypofunction by inhibition of glandular cholinesterase. Rheumatology (Oxford). 2005;44:449–455.
   PubMed Web of Science ®Google Scholar
• Capolunghi F, Rosado MM, Cascioli S, et al. Pharmacological inhibition of TLR9 activation blocks autoantibody production in human B cells from SLE patients. Rheumatology. 2010;49:2281–2289.
   PubMed Web of Science ®Google Scholar
• Gottenberg J-E, Ravaud P, Puéchal X, et al. Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome. JAMA. 2014;312:249.
   PubMed Web of Science ®Google Scholar
• Zheng L, Zhang Z, Yu C, et al. Expression of toll-like receptors 7, 8, and 9 in primary Sjögren’s syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol. 2010;109:844–850.
   PubMed Web of Science ®Google Scholar
• De S, Zhou H, DeSantis D, et al. Erlotinib protects against LPS-induced endotoxicity because TLR4 needs EGFR to signal. Proc Natl Acad Sci U S A. 2015;112:9680–9685.
   PubMed Web of Science ®Google Scholar
• Yamashita M, Chattopadhyay S, Fensterl V, et al. Epidermal growth factor receptor is essential for toll-like receptor 3 signaling. Sci Signal. 2012;5:ra50–ra50.
   PubMed Web of Science ®Google Scholar
• Hsu D, Fukata M, Hernandez YG, et al. Toll-like receptor 4 differentially regulates epidermal growth factor-related growth factors in response to intestinal mucosal injury. Lab Invest. 2010;90:1295–1305.
   PubMed Web of Science ®Google Scholar
• Chen W, Lin J, Cao H, et al. Local and systemic IKKε and NFκB signaling associated with Sjögren’s syndrome immunopathogenesis. J Immunol Res. 2015;2015:1–9.
   Google Scholar
• Saraux A, J-O P, Devauchelle-Pensec V. Treatment of primary Sjögren syndrome. Nat Rev Rheumatol. 2016;12:456–471.
   PubMed Web of Science ®Google Scholar
• Groom J, Kalled SL, Cutler AH, et al. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren’s syndrome. J Clin Invest. 2002;109:59–68.
   PubMed Web of Science ®Google Scholar
• Nordmark G, Wang C, Vasaitis L, et al. Association of genes in the NF-κB pathway with antibody-positive primary Sjögren’s syndrome. Scand J Immunol. 2013;78:447–454.
   PubMed Web of Science ®Google Scholar
• Ou -T-T, Lin C-H, Lin Y-C, et al. IkBα promoter polymorphisms in patients with primary Sjögren’s syndrome. J Clin Immunol. 2008;28:440–444.
   PubMed Web of Science ®Google Scholar
• Hara M, Abe T, Sugawara S, et al. Long-term safety study of iguratimod in patients with rheumatoid arthritis. 2007;17(1):10-16.
   Google Scholar
• Sisto M, Lisi S, Lofrumento DD, et al. Salivary gland expression level of IκBα regulatory protein in Sjögren’s syndrome. J Mol Histol. 2013;44:447–454.
   PubMed Web of Science ®Google Scholar
• Nakamura H, Kawakami A, Ida H, et al. EGF activates PI3K-Akt and NF-κB via distinct pathways in salivary epithelial cells in Sjögren’s syndrome. Rheumatol Int. 2007;28:127–136.
   PubMed Web of Science ®Google Scholar
• Kwok S-K, Cho M-L, Her Y-M, et al. TLR2 ligation induces the production of IL-23/IL-17 via IL-6, STAT3 and NF-kB pathway in patients with primary Sjogren’s syndrome. Arthritis Res Ther. 2012;14:R64.
   PubMed Web of Science ®Google Scholar
• Sisto M, Lorusso L, Lisi S. TLR2 signals via NF-κB to drive IL-15 production in salivary gland epithelial cells derived from patients with primary Sjögren’s syndrome. Clin Exp Med. 2016;17(3):1–10.
   PubMed Web of Science ®Google Scholar
• Lisi S, Sisto M, Lofrumento DD, et al. Sjögren’s syndrome autoantibodies provoke changes in gene expression profiles of inflammatory cytokines triggering a pathway involving TACE/NF-κB. Lab Invest. 2012;92:615–624.
   PubMed Web of Science ®Google Scholar
• Wei L, Xiong H, Li W, et al. Upregulation of IL-6 expression in human salivary gland cell line by IL-17 via activation of p38 MAPK, ERK, PI3K/Akt, and NF-κB pathways. J Oral Pathol Med. 2018;47:847–855.
   PubMed Web of Science ®Google Scholar
• Lilienbaum A, Israël A. From calcium to NF-kappa B signaling pathways in neurons. Mol Cell Biol. 2003;23:2680–2698.
   PubMed Web of Science ®Google Scholar
• Tamiya T, Kashiwagi I, Takahashi R, et al. Suppressors of cytokine signaling (SOCS) proteins and JAK/STAT pathways. Arterioscler Thromb Vasc Biol. 2011;31:980–985.
   PubMed Web of Science ®Google Scholar
• Vartoukian SR, Tilakaratne WM, Seoudi N, et al. Dysregulation of the suppressor of cytokine signalling 3-signal transducer and activator of transcription-3 pathway in the aetiopathogenesis of Sjögren’s syndrome. Clin Exp Immunol. 2014;177:618–629.
   PubMed Web of Science ®Google Scholar
• Lee J, Lee J, Kwok S, et al. JAK ‐1 inhibition suppresses interferon‐induced BAFF production in human salivary gland. Arthritis Rheumatol. 2018;70:2057–2066.
   PubMed Web of Science ®Google Scholar
• Lee J, Lee J, Baek S-Y, et al. THU0264 A selective JAK1 inhibitor, filgotinib suppresses lymphocytic infiltration in salivary gland of non obese diabetic mice via suppression of baff production of salivary gland epithelial cells. Ann Rheum Dis. 2016;75:283.2–283.
   Web of Science ®Google Scholar
• Maimets M, Rocchi C, Bron R, et al. Long-term in vitro expansion of salivary gland stem cells driven by Wnt signals. Stem Cell Reports. 2016;6:150–162.
   PubMed Web of Science ®Google Scholar
• Knox SM, Lombaert IMA, Haddox CL, et al. Parasympathetic stimulation improves epithelial organ regeneration. Nat Comm. 2013;4:1494.
   PubMed Web of Science ®Google Scholar
• David M, Wong L, Flavell R, et al. STAT activation by epidermal growth factor (EGF) and amphiregulin. Requirement for the EGF receptor kinase but not for tyrosine phosphorylation sites or JAK1. J Biol Chem. 1996;271:9185–9188.
   PubMed Web of Science ®Google Scholar
• Okuma A, Hoshino K, Ohba T, et al. Enhanced apoptosis by disruption of the STAT3-IκB-ζ signaling pathway in epithelial cells induces Sjögren’s syndrome-like autoimmune disease. Immunity. 2013;38:450–460.
   PubMed Web of Science ®Google Scholar
• Abdelhamed S, Ogura K, Yokoyama S, et al. AKT-STAT3 pathway as a downstream target of EGFR signaling to regulate PD-L1 expression on NSCLC cells. J Cancer. 2016;7:1579–1586.
   PubMed Web of Science ®Google Scholar
• Hall BE, Zheng C, Swaim WD, et al. Conditional overexpression of TGF-β1 disrupts mouse salivary gland development and function. Lab Invest. 2010;90:543–555.
   PubMed Web of Science ®Google Scholar
• Moustakas A, Pardali K, Gaal A, et al. Mechanisms of TGF-β signaling in regulation of cell growth and differentiation. Immunol Lett. 2002;82:85–91.
   PubMed Web of Science ®Google Scholar
• Fragoso MA, Patel AK, Nakamura REI, et al. The Wnt/β-catenin pathway cross-talks with STAT3 signaling to regulate survival of retinal pigment epithelium cells. Gottardi C, editor. PLoS One. 2012;7:e46892.
   PubMed Web of Science ®Google Scholar
• Kawada M, Seno H, Uenoyama Y, et al. Signal transducers and activators of transcription 3 activation is involved in nuclear accumulation of beta-catenin in colorectal cancer. Cancer Res. 2006;66:2913–2917.
   PubMed Web of Science ®Google Scholar
• Yan S, Zhou C, Zhang W, et al. β-Catenin/TCF pathway upregulates STAT3 expression in human esophageal squamous cell carcinoma. Cancer Lett. 2008;271:85–97.
   PubMed Web of Science ®Google Scholar
• Cordero JB, Stefanatos RK, Myant K, et al. Non-autonomous crosstalk between the Jak/Stat and Egfr pathways mediates Apc1-driven intestinal stem cell hyperplasia in the drosophila adult midgut. Development. 2012;139:4524–4535.
   PubMed Web of Science ®Google Scholar
• Yu Y, Gu S, Li W, et al. Smad7 enables STAT3 activation and promotes pluripotency independent of TGF-β signaling. Proc Natl Acad Sci U S A. 2017;114:10113–10118.
   PubMed Web of Science ®Google Scholar
• Abu-Helu RF, Dimitriou ID, Kapsogeorgou EK, et al. Induction of salivary gland epithelial cell injury in Sjogren’s syndrome: in vitro assessment of T cell-derived cytokines and fas protein expression. J Autoimmun. 2001;17:141–153.
   PubMed Web of Science ®Google Scholar
• Ping L, Ogawa N, Sugai S. Novel role of CD40 in Fas-dependent apoptosis of cultured salivary epithelial cells from patients with Sjögren’s syndrome. Arthritis Rheum. 2005;52:573–581.
   PubMed Web of Science ®Google Scholar
• Gump JM, Thorburn A. Autophagy and apoptosis: what is the connection? Trends Cell Biol. 2011;21:387–392.
   PubMed Web of Science ®Google Scholar
• Terunuma A, Limgala RP, Park CJ, et al. Efficient procurement of epithelial stem cells from human tissue specimens using a Rho-associated protein kinase inhibitor Y-27632. Tissue Eng Part A. 2010;16:1363–1368.
   PubMed Web of Science ®Google Scholar
• Kong L, Ogawa N, McGuff HS, et al. Bcl-2 family expression in salivary glands from patients with primary Sjögren’s syndrome: involvement of Bax in salivary gland destruction. Clin Immunol Immunopathol. 1998;88:133–141.
   PubMedGoogle Scholar
• Jackson NM, Ceresa BP. EGFR-mediated apoptosis via STAT3. Exp Cell Res. 2017;356:93–103.
   PubMed Web of Science ®Google Scholar
• Zhou X-J ZH. Autophagy in immunity. Autophagy. 2012;8:1286–1299.
   PubMedGoogle Scholar
• Delgado MA, Deretic V. Toll-like receptors in control of immunological autophagy. Cell Death Differ. 2009;16:976–983.
   PubMed Web of Science ®Google Scholar
• Delgado MA, Elmaoued RA, Davis AS, et al. Toll-like receptors control autophagy. Embo J. 2008;27:1110–1121.
   PubMed Web of Science ®Google Scholar
• Into T, Inomata M, Takayama E, et al. Autophagy in regulation of Toll-like receptor signaling. Cell Signal. 2012;24:1150–1162.
   PubMed Web of Science ®Google Scholar
• Silver N, Proctor GB, Arno M, et al. Activation of mTOR coincides with autophagy during ligation-induced atrophy in the rat submandibular gland. Cell Death Dis. 2010;1:e14–e14.
   PubMed Web of Science ®Google Scholar
• Fu J, Shi H, Cao N, et al. Toll-like receptor 9 signaling promotes autophagy and apoptosis via divergent functions of the p38/JNK pathway in human salivary gland cells. Exp Cell Res. 2019;375:51-59.
   Web of Science ®Google Scholar
• Nayar S, Campos J, Smith CG, et al. Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren’s syndrome. Ann Rheum Dis. 2019;78:249–260.
   PubMed Web of Science ®Google Scholar
• Schwartz M. Rho signalling at a glance. J Cell Sci. 2004;117:5457–5458.
   PubMed Web of Science ®Google Scholar
• Sun -C-C, Chiu H-T, Lin Y-F, et al. Y-27632, a ROCK inhibitor, promoted limbal epithelial cell proliferation and corneal wound healing. Liu X, editor. PLoS One. 2015;10:e0144571.
   PubMed Web of Science ®Google Scholar
• Daley WP, Gulfo KM, Sequeira SJ, et al. Identification of a mechanochemical checkpoint and negative feedback loop regulating branching morphogenesis. Dev Biol. 2009;336:169–182.
   PubMed Web of Science ®Google Scholar
• Crema VO, Hamassaki DE, Santos MF. Small Rho GTPases are important for acinus formation in a human salivary gland cell line. Cell Tissue Res. 2006;325:493–500.
   PubMed Web of Science ®Google Scholar
• Gervais EM, Sequeira SJ, Wang W, et al. Par-1b is required for morphogenesis and differentiation of myoepithelial cells during salivary gland development. Organogenesis. 2016;12:194–216.
   PubMed Web of Science ®Google Scholar
• Li J, Cong X, Zhang Y, et al. ZO-1 and −2 are required for TRPV1-modulated paracellular permeability. J Dent Res. 2015;94:1748–1756.
   PubMed Web of Science ®Google Scholar
• Lee J, Park S, Roh S. Y-27632, a ROCK inhibitor, delays senescence of putative murine salivary gland stem cells in culture. Arch Oral Biol. 2015;60:875–882.
   PubMed Web of Science ®Google Scholar
• Hwang S-M, Jin M, Shin YH, et al. Role of LPA and the hippo pathway on apoptosis in salivary gland epithelial cells. Exp Mol Med. 2014;46:e125–e125.
   PubMed Web of Science ®Google Scholar
• Han C, An GH, Woo D-H, et al. Rho-associated kinase inhibitor enhances the culture condition of isolated mouse salivary gland cells in vitro. Tissue Cell. 2018;54:20–25.
   PubMed Web of Science ®Google Scholar